Cargando…
Blocking CCN2 Reduces Established Palmar Neuromuscular Fibrosis and Improves Function Following Repetitive Overuse Injury
The matricellular protein cell communication factor 2/connective tissue growth factor (CCN2/CTGF) is critical to development of neuromuscular fibrosis. Here, we tested whether anti-CCN2 antibody treatment will reduce established forepaw fibro-degenerative changes and improve function in a rat model...
Autores principales: | Lambi, Alex G., DeSante, Robert J., Patel, Parth R., Hilliard, Brendan A., Popoff, Steven N., Barbe, Mary F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531056/ https://www.ncbi.nlm.nih.gov/pubmed/37762168 http://dx.doi.org/10.3390/ijms241813866 |
Ejemplares similares
-
Blocking CTGF/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury
por: Barbe, Mary F., et al.
Publicado: (2020) -
Blocking CCN2 Reduces Progression of Sensorimotor Declines and Fibrosis in a Rat Model of Chronic Repetitive Overuse
por: Barbe, Mary F., et al.
Publicado: (2019) -
Blocking CCN2 Reduces Established Bone Loss Induced by Prolonged Intense Loading by Increasing Osteoblast Activity in Rats
por: Lambi, Alex G, et al.
Publicado: (2023) -
Blocking CTGF/CCN2 reverses neural fibrosis and sensorimotor declines in a rat model of overuse‐induced median mononeuropathy
por: Barbe, Mary F., et al.
Publicado: (2020) -
Development of Normal and Cleft Palate: A Central Role for Connective Tissue Growth Factor (CTGF)/CCN2
por: Tarr, Joseph T., et al.
Publicado: (2018)